Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial type I signal peptidase (SPase I) is an essential membrane-bound serine protease found in all bacteria, where it plays a pivotal role in the protein secretion pathway (UniProt). Its primary function is to cleave the amino-terminal signal peptide from pre-proteins as they emerge from the Sec or Tat translocation machinery, a step necessary for the maturation and proper localization of extracellular and periplasmic proteins (PubMed: 12446561). Because SPase I is indispensable for bacterial growth and possesses a unique catalytic Ser-Lys dyad that differs significantly from the catalytic mechanisms of eukaryotic signal peptidases, it is considered a high-priority target for novel antibiotic discovery (Nature: 10.1038/s41586-018-0483-6). Inhibitors such as the natural product arylomycins and their synthetic derivatives, like G-7485, have demonstrated potent antibacterial activity by blocking this cleavage event, leading to the accumulation of toxic unprocessed proteins in the bacterial membrane (Science: 10.1126/science.aar5592). This mechanism of action is effective against a wide range of pathogens, including multi-drug resistant strains, making SPase I a promising focus for future therapeutic development.
Inhibitors bind to the catalytic site of SPase I, blocking the Ser-Lys dyad from cleaving signal peptides. This prevents the maturation of secreted proteins, causing them to remain tethered to the cytoplasmic membrane, which triggers bacterial cell death (PubMed: 12446561).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial type I signal peptidase (SPase I) (SPase I).